HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Ask the Analyst
PDF Library
RSS Feeds
Subscribe
Advertising
Partnered Content
Report Store
UsernamePublicRestriction
Tags:
Sales & Earnings Japan Europe

Taisho Boosted By Acquisitions As Japanese Business Struggles

  • News

Executive Summary

Acquiring France's UPSA helped to lift Taisho's sales in the 12 months ended 31 March 2020, as its domestic Japanese business faltered.

You may also be interested in...



French Ban On Hemp-Derived CBD Judged Contrary To EU Law

France cannot ban the sale of CBD oil derived from the whole hemp plant and should introduce less restrictive regulations on cannabidiol, according to an advocate general of Europe's highest court. The case will likely set a precedent for CBD regulation in the EU.

Karo Pharma Grabs J&J’s Pevaryl Brand In Europe

Karo has picked up the full European rights to the Pevaryl antifungal brand from Johnson & Johnson.

Quick Guide To CBD Regulation In Europe

A brief overview of the regulations governing the sale of CBD supplements in the European Union.

Table

View full table

Topics

Tags:
Sales & Earnings Japan Europe
UsernamePublicRestriction

Register

WI964834

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By